Cello Health

Cello Health are a passionate team of global advisers, expert at navigating life science clients to confident critical decisions

Join our team

We are always on the lookout for great people who want to do things on the cutting edge of science and technology

Join us

Teams of experts

We are expert navigators helping guide our clients to more successful outcomes

Our people

With a global perspective

We work with 24 of the top 25 pharmaceutical companies as well as 100s of biotechs globally from our offices in the US and Europe

Our locations

Giving back

We support a variety of causes across our global business

We provide multiple perspectives, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices

We recognise that the journey is often as important as the destination. We work like an extension of your team so your overall journey with us feels better

How we work What we do
We provide multiple perspectives, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices

Read our latest News & Views >

Sonar – your ‘finger on the pulse’ in the digital space
18 November 2021 views
Sonar – your ‘finger on the pulse’ in the digital space

Introducing Sonar – a new syndicated offer from Cello Health

Cello Health Announces New Syndicated Research Program
12 November 2021 views
Cello Health Announces New Syndicated Research Program

Cello Health has developed a suite of syndicated offerings tailored to support your strategic objectives at key stages in the product lifecycle. Our customizable group of reports will provide regular actionable insights from market landscape maps based on social media data, as well as ongoing tracking of HCP preferences and channel behavior.

The US Forecaster’s Check List for Japan: A World of Difference
24 September 2021 views
The US Forecaster’s Check List for Japan: A World of Difference

The US Forecaster’s Check List for Japan: A World of Difference

Expanding the valuation of a biopharmaceutical asset to Japan requires a new mindset in nearly every input of forecasting, with many pitfalls. Doug Willson, Senior Vice President, Cello Health Advantage and Tiffany Ahlers, Chief Commercial Officer, Mycovia Pharmaceuticals Inc., share a checklist to improve the rigor and validity of product forecasts for Japan.

Let’s work together

The journey to scientific and commercial success is often complex and always critical. If you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us